Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $408M | $2.21B | -81.50% |
Cost of Revenue | $211M | $1.52B | -86.15% |
Operating Income | $-2.63B | $-2.23B | -17.73% |
Net Income | $-2.45B | $-1.3B | -88.62% |
EPS (Basic) | $-6.41 | $-3.39 | -89.09% |
EPS (Diluted) | $-6.41 | $-3.39 | -89.09% |
R&D Expense | $2.28B | $2.28B | +0.22% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $15.68B | $21.88B | -28.35% |
Current Assets | $9.66B | $10.6B | -8.85% |
Total Liabilities | $3.97B | $4.93B | -19.59% |
Current Liabilities | $2.36B | $3.12B | -24.34% |
Stockholders' Equity | $11.71B | $16.95B | -30.90% |
Cash & Equivalents | $2.48B | $3.8B | -34.81% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-2.26B | $-2.14B | -5.75% |
Investing Cash Flow | $1.77B | $3.96B | -55.32% |
Financing Cash Flow | $48M | $-1.21B | +103.97% |
Share Buybacks | $0 | $1.15B | -100.00% |
D&A | $75M | $168M | -55.36% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -644.4% | -101.2% | -543.14% |
Net Margin | -601.5% | — | — |
ROE | -21.0% | — | — |
ROA | -15.7% | — | — |
Current Ratio | $4.088 | — | — |
Debt to Equity | $0.339 | — | — |
Other companies in Biotechnology